GENETIC ANALYSIS NK -60 (8V8) — Net Asset Momentum
GENETIC ANALYSIS NK -60 (8V8) recorded a net asset momentum of 20.4% as of December 2025, with net assets of €27.08 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check GENETIC ANALYSIS NK -60 tangible book value ratio to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
GENETIC ANALYSIS NK -60 Net Asset Momentum (2021–2025)
This chart tracks GENETIC ANALYSIS NK -60's year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is +20.4%, with net assets of €27.08 Million EUR as of December 2025. Read GENETIC ANALYSIS NK -60 (8V8) total liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for GENETIC ANALYSIS NK -60 (2021–2025)
The table below shows the complete annual net asset history for GENETIC ANALYSIS NK -60 from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see how much is GENETIC ANALYSIS NK -60 worth.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €27.08 Million | €52.45 Million | €25.37 Million | ▲ +20.4% |
| 2024 | €22.49 Million | €42.38 Million | €19.88 Million | ▼ -29.7% |
| 2023 | €32.00 Million | €53.49 Million | €21.49 Million | ▼ -27.5% |
| 2022 | €44.14 Million | €64.42 Million | €20.28 Million | ▼ -38.8% |
| 2021 | €72.09 Million | €83.49 Million | €11.40 Million | — |